222 related articles for article (PubMed ID: 1119711)
1. Anesthetic biotransformation and renal function in obese patients during and after methoxyflurane or halothane anesthesia.
Young SR; Stoelting RK; Peterson C; Madura JA
Anesthesiology; 1975 Apr; 42(4):451-7. PubMed ID: 1119711
[TBL] [Abstract][Full Text] [Related]
2. Methoxyflurane anesthesia in pediatric patients: evaluation of anesthetic metabolism and renal function.
Stoelting RK; Peterson C
Anesthesiology; 1975 Jan; 42(1):26-9. PubMed ID: 1111367
[TBL] [Abstract][Full Text] [Related]
3. Toxicity following methoxyflurane anaesthesia. IV. The role of obesity and the effect of low dose anaesthesia on fluoride metabolism and renal function.
Samuelson PN; Merin RG; Taves DR; Freeman RB; Calimlim JF; Kumazawa T
Can Anaesth Soc J; 1976 Sep; 23(5):465-79. PubMed ID: 971456
[TBL] [Abstract][Full Text] [Related]
4. Methoxyflurane biotransformation and renal function following methoxyflurane administration for vaginal delivery or cesarean section.
Young SR; Stoelting RK; Bond VK; Peterson C
Anesth Analg; 1976; 55(3):415-9. PubMed ID: 945023
[TBL] [Abstract][Full Text] [Related]
5. Serum and urine inorganic fluoride concentrations and urine oxalate concentrations following methoxyflurane anesthesia in the dog.
Brunson DB; Stowe CM; McGrath CJ
Am J Vet Res; 1979 Feb; 40(2):197-203. PubMed ID: 464357
[TBL] [Abstract][Full Text] [Related]
6. The effect of cimetidine on anesthetic metabolism and toxicity.
Wood M; Uetrecht J; Phythyon JM; Shay S; Sweetman BJ; Shaheen O; Wood AJ
Anesth Analg; 1986 May; 65(5):481-8. PubMed ID: 3963434
[TBL] [Abstract][Full Text] [Related]
7. Biodegradation of halothane, enflurane and methoxyflurane.
Sakai T; Takaori M
Br J Anaesth; 1978 Aug; 50(8):785-91. PubMed ID: 678365
[TBL] [Abstract][Full Text] [Related]
8. Halothane biotransformation in obese and nonobese patients.
Bentley JB; Vaughan RW; Gandolfi AJ; Cork RC
Anesthesiology; 1982 Aug; 57(2):94-7. PubMed ID: 7091749
[TBL] [Abstract][Full Text] [Related]
9. I-653 resists degradation in rats.
Koblin DD; Eger EI; Johnson BH; Konopka K; Waskell L
Anesth Analg; 1988 Jun; 67(6):534-8. PubMed ID: 3377207
[TBL] [Abstract][Full Text] [Related]
10. Serum inorganic fluoride concentrations during and after halothane, fluroxene, and methoxyflurane anesthesia in man.
Creasser C; Stoelting RK
Anesthesiology; 1973 Nov; 39(5):537-40. PubMed ID: 4147705
[No Abstract] [Full Text] [Related]
11. Serum inorganic fluoride levels in obese patients during and after enflurane anesthesia.
Bentley JB; Vaughan RW; Miller MS; Calkins JM; Gandolfi AJ
Anesth Analg; 1979; 58(5):409-12. PubMed ID: 573567
[TBL] [Abstract][Full Text] [Related]
12. Serum inorganic fluoride and renal function in dogs after methoxyflurane anesthesia, tetracycline treatment, and surgical manipulation.
Fleming JT; Pedersoli WM
Am J Vet Res; 1980 Dec; 41(12):2025-9. PubMed ID: 7212437
[TBL] [Abstract][Full Text] [Related]
13. Increased serum bromide concentration after halothane anesthesia in man.
Johnstone RE; Kennell EM; Behar MG; Brummund W; Ebersole RC; Shaw LM
Anesthesiology; 1975 May; 42(5):598-601. PubMed ID: 1130724
[TBL] [Abstract][Full Text] [Related]
14. Serum fluoride concentration, renal, and hepatic function test results in dogs with methoxyflurane anesthesia.
Pedersoli WM
Am J Vet Res; 1977 Jul; 38(7):949-53. PubMed ID: 883722
[TBL] [Abstract][Full Text] [Related]
15. Methoxyflurane metabolism and renal dysfunction: clinical correlation in man.
Mazze RI; Trudell JR; Cousins MJ
Anesthesiology; 1971 Sep; 35(3):247-52. PubMed ID: 5095537
[No Abstract] [Full Text] [Related]
16. Effect of enzyme induction on nephrotoxicity of halothane-related compounds.
Hitt BA; Mazze RI
Environ Health Perspect; 1977 Dec; 21():179-83. PubMed ID: 612443
[TBL] [Abstract][Full Text] [Related]
17. Effects of prolonged anesthesia with enflurane or halothane on renal function in dogs.
Wickström I; Stefansson T
Acta Anaesthesiol Scand; 1981 Jun; 25(3):228-34. PubMed ID: 7324840
[TBL] [Abstract][Full Text] [Related]
18. Does evidence of reductive halothane biotransformation correlate with hepatic binding of metabolites in obese patients?
Bentley JB; Vaughan RW; Cork RC; Gandolfi AJ
Anesth Analg; 1981 Aug; 60(8):548-51. PubMed ID: 7196167
[TBL] [Abstract][Full Text] [Related]
19. New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 1): Identification of the nephrotoxic metabolic pathway.
Kharasch ED; Schroeder JL; Liggitt HD; Park SB; Whittington D; Sheffels P
Anesthesiology; 2006 Oct; 105(4):726-36. PubMed ID: 17006072
[TBL] [Abstract][Full Text] [Related]
20. Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidly obese and nonobese patients.
Frink EJ; Malan TP; Brown EA; Morgan S; Brown BR
Anesth Analg; 1993 Jun; 76(6):1333-7. PubMed ID: 8498674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
